Lorophar SRL
0.4 FTELorophar reported total assets of 234,299 € at the end of the 2025 financial year (annual accounts filed with the NBB on 14 Aug 2026), with 0.4 full-time equivalent.
The score of Lorophar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +42 % Total assets +4 % Headcount (avg FTE) 0 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Lorophar's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 44,679 € | ||||
| Equity | 109,031 € | ||||
| Cash | 74,319 € | ||||
| EBITDA | 86,065 € | ||||
| Total assets | 234,299 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 14 Aug 2026
- Year ended 31 Dec 2024filed on 18 Aug 2025
- Year ended 31 Dec 2023filed on 21 Aug 2024
- Year ended 31 Dec 2022filed on 19 Jun 2023
- Year ended 31 Dec 2021filed on 08 Jul 2022
Lorophar's financial analysis
- Solvency46.5%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Lorophar
Lorophar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0829.202.322
- VAT number
- BE0829202322
- Peppol
- Registered · 0208:0829202322 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 13 Sep 2010
- Registered office
- 4287 Lincent
- Size
- Micro · 0.4 FTE
- Latest accounts
- 2025 · filed on 14 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Lorophar (SRL) has been based in Lincent since 2010, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 44,679 € and equity of 109,031 €; its revenue is not published. With 0.4 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 46.5%, above the median of its sector (41.5%).
Companies similar to Lorophar
Companies in the same business, of comparable size and area, outside its group.
- Apotheek VAN Hoecke Retail sale of pharmaceutical products Kortrijk · balance sheet 234,019 €
- Apoteek DE Decker Retail sale of pharmaceutical products Lebbeke · balance sheet 234,587 €
- SyGoBioClin Retail sale of pharmaceutical products Kraainem · balance sheet 235,248 €
- Pharmacie Keereman Retail sale of pharmaceutical products Schaerbeek · balance sheet 235,291 €
- DVL Retail sale of pharmaceutical products Dilbeek · balance sheet 235,408 €
- Elapharma Retail sale of pharmaceutical products Brussels · balance sheet 236,353 €
- Pharmaphie EVG Retail sale of pharmaceutical products Evergem · balance sheet 229,312 €
- Lmedication Retail sale of pharmaceutical products Fleurus · balance sheet 228,494 €
Frequently asked questions about Lorophar
What is the revenue of Lorophar?
Lorophar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Lorophar?
In Belgium, the VAT number is the company number prefixed with BE: BE0829202322 for Lorophar, if the company is VAT-registered. Its company number (CBE) is 0829.202.322.
Where is the registered office of Lorophar?
According to the CBE register, the registered office of Lorophar is in 4287 Lincent.
What is the equity of Lorophar?
At the close of the 2025 financial year, the equity of Lorophar amounts to 109,031 €, a solvency of 46.5% of total assets.
How many people work at Lorophar?
0.4 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Lorophar?
The register lists 1 active mandates at Lorophar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Lorophar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →